Company intelligence / Profile preview

Shanghai Biozhe Biotech

Ownership: Private
Development stage: Other

Overview

Shanghai ZJ Bio-Tech has developed over 300 types of PCR kits covering nearly all notifiable infectious diseases. More than thirty products have medical device registration certificates; over two hundred have CE certification. Their products were included in WHO procurement lists during major global health emergencies.

Therapeutic areas: Women's HealthInfectious Diseases
Modalities: PCR-based diagnostic kits (Real-time fluorescence PCR)Molecular diagnostic reagents and instruments
Industry: Molecular Diagnostics

Partnerships

WHO procurement supplier during global emergenciesUnited Nations supplier

Beyond the preview

Go deeper on Shanghai Biozhe Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Biozhe Biotech.

Explore the full profile